Adenovector-mediated expression of human thrombopoietin cDNA in immune- compromised mice: Insights into the pathophysiology of osteomyelofibrosis

Beat M. Frey, Shahin Rafii, Michael Teterson, Dan Eaton, Ronald Crystal, Malcolm A.S. Moore

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Thrombopoietin (TPO) cDNA can be effectively delivered in vivo by adenovectors. Immune normal mice (BALB/c) and syngeneic mice with variable degrees of immune dysfunction nu, SCID, and NOD-SCID) were treated with an adenovirus vector expressing the human TPO cDNA (AdTPO). Platelet peaks were significantly higher in SCID and NOD-SCID mice compared with BALB/c and nu mice. Human plasma TPO concentration correlated with the platelet counts. SCID and NOD-SCID mice exhibited also granulocytosis and increased numbers of hemopoietic progenitors in bone marrow. Following platelet peak, BALB/c mice developed autoantibodies against murine TPO leading to thrombocytopenia and depletion of megakaryocytes and hemopoietic progenitors in bone marrow. AdTPO-treated SCID mice developed osteomyelofibrosis and extramedullary/extrasplenal hemopoiesis. In contrast, NOD-SCID mice with a similar magnitude of TPO overexpression did not show fibrotic changes in bone marrow. We conclude, first, that a chronic high level of TPO overexpression stimulates megakaryocytopoiesis and myelopoiesis leading to thrombocytosis and granulocytosis. Second, increased megakaryocytopoiesis is not sufficient for development of secondary osteomyelofibrosis. The functionally deficient monocytes and macrophages of NOD-SCID mice probably prevented fibrotic marrow changes. Third, immune deficiency enhances expression of adenovirally mediated transgenes, and fourth, xenogeneic transgene delivered by adenovector to a host with normal immune functions may induce loss of immune tolerance and autoimmune phenomenon.

Original languageEnglish
Pages (from-to)691-699
Number of pages9
JournalJournal of Immunology
Volume160
Issue number2
Publication statusPublished - 15 Jan 1998
Externally publishedYes

Fingerprint

Thrombopoietin
SCID Mice
Inbred NOD Mouse
Complementary DNA
Bone Marrow
Thrombopoiesis
Transgenes
Blood Platelets
Megakaryocyte Progenitor Cells
Myelopoiesis
Thrombocytosis
Immune Tolerance
Platelet Count
Adenoviridae
Thrombocytopenia
Autoantibodies
Monocytes
Macrophages

ASJC Scopus subject areas

  • Immunology

Cite this

Adenovector-mediated expression of human thrombopoietin cDNA in immune- compromised mice : Insights into the pathophysiology of osteomyelofibrosis. / Frey, Beat M.; Rafii, Shahin; Teterson, Michael; Eaton, Dan; Crystal, Ronald; Moore, Malcolm A.S.

In: Journal of Immunology, Vol. 160, No. 2, 15.01.1998, p. 691-699.

Research output: Contribution to journalArticle

Frey, Beat M. ; Rafii, Shahin ; Teterson, Michael ; Eaton, Dan ; Crystal, Ronald ; Moore, Malcolm A.S. / Adenovector-mediated expression of human thrombopoietin cDNA in immune- compromised mice : Insights into the pathophysiology of osteomyelofibrosis. In: Journal of Immunology. 1998 ; Vol. 160, No. 2. pp. 691-699.
@article{269596b1532e4d90923fe0bc4415469c,
title = "Adenovector-mediated expression of human thrombopoietin cDNA in immune- compromised mice: Insights into the pathophysiology of osteomyelofibrosis",
abstract = "Thrombopoietin (TPO) cDNA can be effectively delivered in vivo by adenovectors. Immune normal mice (BALB/c) and syngeneic mice with variable degrees of immune dysfunction nu, SCID, and NOD-SCID) were treated with an adenovirus vector expressing the human TPO cDNA (AdTPO). Platelet peaks were significantly higher in SCID and NOD-SCID mice compared with BALB/c and nu mice. Human plasma TPO concentration correlated with the platelet counts. SCID and NOD-SCID mice exhibited also granulocytosis and increased numbers of hemopoietic progenitors in bone marrow. Following platelet peak, BALB/c mice developed autoantibodies against murine TPO leading to thrombocytopenia and depletion of megakaryocytes and hemopoietic progenitors in bone marrow. AdTPO-treated SCID mice developed osteomyelofibrosis and extramedullary/extrasplenal hemopoiesis. In contrast, NOD-SCID mice with a similar magnitude of TPO overexpression did not show fibrotic changes in bone marrow. We conclude, first, that a chronic high level of TPO overexpression stimulates megakaryocytopoiesis and myelopoiesis leading to thrombocytosis and granulocytosis. Second, increased megakaryocytopoiesis is not sufficient for development of secondary osteomyelofibrosis. The functionally deficient monocytes and macrophages of NOD-SCID mice probably prevented fibrotic marrow changes. Third, immune deficiency enhances expression of adenovirally mediated transgenes, and fourth, xenogeneic transgene delivered by adenovector to a host with normal immune functions may induce loss of immune tolerance and autoimmune phenomenon.",
author = "Frey, {Beat M.} and Shahin Rafii and Michael Teterson and Dan Eaton and Ronald Crystal and Moore, {Malcolm A.S.}",
year = "1998",
month = "1",
day = "15",
language = "English",
volume = "160",
pages = "691--699",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Adenovector-mediated expression of human thrombopoietin cDNA in immune- compromised mice

T2 - Insights into the pathophysiology of osteomyelofibrosis

AU - Frey, Beat M.

AU - Rafii, Shahin

AU - Teterson, Michael

AU - Eaton, Dan

AU - Crystal, Ronald

AU - Moore, Malcolm A.S.

PY - 1998/1/15

Y1 - 1998/1/15

N2 - Thrombopoietin (TPO) cDNA can be effectively delivered in vivo by adenovectors. Immune normal mice (BALB/c) and syngeneic mice with variable degrees of immune dysfunction nu, SCID, and NOD-SCID) were treated with an adenovirus vector expressing the human TPO cDNA (AdTPO). Platelet peaks were significantly higher in SCID and NOD-SCID mice compared with BALB/c and nu mice. Human plasma TPO concentration correlated with the platelet counts. SCID and NOD-SCID mice exhibited also granulocytosis and increased numbers of hemopoietic progenitors in bone marrow. Following platelet peak, BALB/c mice developed autoantibodies against murine TPO leading to thrombocytopenia and depletion of megakaryocytes and hemopoietic progenitors in bone marrow. AdTPO-treated SCID mice developed osteomyelofibrosis and extramedullary/extrasplenal hemopoiesis. In contrast, NOD-SCID mice with a similar magnitude of TPO overexpression did not show fibrotic changes in bone marrow. We conclude, first, that a chronic high level of TPO overexpression stimulates megakaryocytopoiesis and myelopoiesis leading to thrombocytosis and granulocytosis. Second, increased megakaryocytopoiesis is not sufficient for development of secondary osteomyelofibrosis. The functionally deficient monocytes and macrophages of NOD-SCID mice probably prevented fibrotic marrow changes. Third, immune deficiency enhances expression of adenovirally mediated transgenes, and fourth, xenogeneic transgene delivered by adenovector to a host with normal immune functions may induce loss of immune tolerance and autoimmune phenomenon.

AB - Thrombopoietin (TPO) cDNA can be effectively delivered in vivo by adenovectors. Immune normal mice (BALB/c) and syngeneic mice with variable degrees of immune dysfunction nu, SCID, and NOD-SCID) were treated with an adenovirus vector expressing the human TPO cDNA (AdTPO). Platelet peaks were significantly higher in SCID and NOD-SCID mice compared with BALB/c and nu mice. Human plasma TPO concentration correlated with the platelet counts. SCID and NOD-SCID mice exhibited also granulocytosis and increased numbers of hemopoietic progenitors in bone marrow. Following platelet peak, BALB/c mice developed autoantibodies against murine TPO leading to thrombocytopenia and depletion of megakaryocytes and hemopoietic progenitors in bone marrow. AdTPO-treated SCID mice developed osteomyelofibrosis and extramedullary/extrasplenal hemopoiesis. In contrast, NOD-SCID mice with a similar magnitude of TPO overexpression did not show fibrotic changes in bone marrow. We conclude, first, that a chronic high level of TPO overexpression stimulates megakaryocytopoiesis and myelopoiesis leading to thrombocytosis and granulocytosis. Second, increased megakaryocytopoiesis is not sufficient for development of secondary osteomyelofibrosis. The functionally deficient monocytes and macrophages of NOD-SCID mice probably prevented fibrotic marrow changes. Third, immune deficiency enhances expression of adenovirally mediated transgenes, and fourth, xenogeneic transgene delivered by adenovector to a host with normal immune functions may induce loss of immune tolerance and autoimmune phenomenon.

UR - http://www.scopus.com/inward/record.url?scp=0031963996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031963996&partnerID=8YFLogxK

M3 - Article

C2 - 9551904

AN - SCOPUS:0031963996

VL - 160

SP - 691

EP - 699

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -